Peter J. Facchini - 01 Jun 2026 Form 4 Insider Report for Enveric Biosciences, Inc. (ENVB)

Reporting relationship: Chief Innovation Officer
Issuer ticker: ENVB
Reported as of: 01 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2026, 16:22:31 UTC
Prior SEC filing: 12 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Peter J. Facchini

Key filing fact

Peter J. Facchini filed Form 4 for Enveric Biosciences, Inc. (ENVB) on 03 Jun 2026.

Key facts

This page summarizes Peter J. Facchini's Form 4 filing for Enveric Biosciences, Inc. (ENVB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2026, 16:22.

Change

Previous filing in this sequence was filed on 12 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001883966 Primary reporting owner

Facchini Peter J.

Relationship: Chief Innovation Officer
Address: C/O ENVERIC BIOSCIENCES, INC., 245 FIRST STREET, RIVERVIEW II, 18TH FL, CAMBRIDGE
Signature: /s/ Peter J. Facchini
Signature date: 03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENVB transaction

Common Stock

Award

Transaction value
Shares: +25,000
Change %: +907%
Price: $0.000000^*
Shares after: 27,755
Date: 01 Jun 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the restricted stock units (the "RSUs") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan, as amended. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock. One-fourth of the RSUs will vest upon the one-year anniversary of the date of issuance. An additional one-thirty-sixth of the RSUs will vest each month following the first vesting date. Any remaining RSUs will vest on the fourth anniversary of the date of issuance. Vesting is conditioned upon continued employment by the Company.

Footnote F2

On October 28, 2025, the common stock of the Company began trading on a split-adjusted basis, pursuant to which every 12 shares of issued and outstanding common stock were reclassified as one share of common stock (the "Reverse Stock Split"). The amount of securities reported in this Form 4 has been adjusted to reflect the Reverse Stock Split.